<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201012049010N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-03-04</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Efficacy and Safety of Respiratory Exercises with Incentive Spirometry in Hospitalized Adult Patients with SARS-CoV-2</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of the integrated drug- incentive spirometry therapy with drug therapy alone on recovery and mortality of patients admitted to hospital with Covid 19</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>160</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60688</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The sampling method in this study was based on Simple randomization (random numbers table). To create a random list in Excel software, 160 samples (two identical groups of 80) were considered in one column, then the RAND function was assigned. In the end, the samples were sorted from low to high. On a daily basis, eligible patients were assigned by the registrants based on the embedded list in two groups: A) control and B) intervention. Registrants, outcome assessors, and the relevant health care team were not aware of the randomization process, Blinding description: Eligible patients were divided into two groups by a two-person group of researchers based on a designed table. For one of the patients, a data collection form with a special code will be determined at the time of enrollment. The data were collected by a separate team of collectors on a daily basis and recorded in a designed online data sheet. Health care providers and the treatment team were also unaware of the allocation of patients to either group. The collected data will be statistically analyzed by the analysis group in groups A and B without group-specific labels.</study_design>
      <phase>3</phase>
      <hc_freetext>Covid19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in this group (from the day of admission to the study) were given the same in addition to pharmacological and non-pharmacological treatments. After each training session, the patients in the intervention group were asked to intervene after a deep breath for 2 to 5 seconds and confinement. Breathe for 1 second, begin to exhale deeply in the spirometer, encourage each time they can take action, then wait for rest until the patient feels the need, then repeat this breathing exercise 4 more times with the same quality. Will repeat. If the patient receives oxygen through the mouth mask, he or she will receive oxygen through the nasal mask during breathing exercises. This group was also asked to continue the same treatment for the given exercise in case of discharge from the hospital for up to 3 months. Intervention 2: Control group: Patients in this group did not receive any additional intervention and received the same drug and non-drug treatments as the intervention group, based on the opinion of the relevant treatment team according to the latest published version of the national protocol.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All collected data can be subscribed in CSV format after identifying the participants. And videos taken from patients during breathing exercises can also be shared if they are satisfied.

When:
Immediately after publishing the article

To whom:
All researchers and individuals working in academic and scientific institutions

Conditions:
For all scientific and therapeutic uses

Where to obtain:
Email the corresponding author and the first author of the relevant article

How to obtain:
After receiving the email, the request will be answered in coordination with the responsible team, and mentioning the source is mandatory

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Bargahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No-16, Mohammadi 12 meter َAlley, Mirmalek St, Farhang Blv, Saadat Abad, Tehan</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۴۳۹۶۳۷۸۵</zip>
        <telephone>+98 21 8868 3799</telephone>
        <email>mmd.bargahi@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mostafa Alavi Moghadam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Hussain hosp, Shahid Maddani St, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1617763141</zip>
        <telephone>+98 21 7343 3000</telephone>
        <email>mostafaalavimoghaddam@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Older age equals 18 years
Patients with Covid 19 (based on diagnostic methods of the latest published version of the National Protocol)
Need to be admitted to a non-intensive care unit
Hospitalization in the last 6 hours</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Any case of CNS disorder that interferes with patient communication and educability
Need to be admitted to the intensive care unit at the time of enrollment
history of lung disease
sPo2&lt;94% (at room air)
Participation in any other clinical trial of an experimental treatment for COVID-19
pregnant woman or man who his spouse is pregnant
history of CHF
Requiring mechanical ventilation at screening
Evidence of multi-organ failure
Recent of ACS
no willingness for enrollment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>U07.1 + J1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>مواردتائید شده کووید 19 با بیماری تنفسی (پنومونی ویروسی) و/یا علایم و نشاته های بیماری تنفسی(تنگی نفس ، سرفه)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in this group (from the day of admission to the study) were given the same in addition to pharmacological and non-pharmacological treatments. After each training session, the patients in the intervention group were asked to intervene after a deep breath for 2 to 5 seconds and confinement. Breathe for 1 second, begin to exhale deeply in the spirometer, encourage each time they can take action, then wait for rest until the patient feels the need, then repeat this breathing exercise 4 more times with the same quality. Will repeat. If the patient receives oxygen through the mouth mask, he or she will receive oxygen through the nasal mask during breathing exercises. This group was also asked to continue the same treatment for the given exercise in case of discharge from the hospital for up to 3 months.</i_keyword>
      <i_keyword>Control group: Patients in this group did not receive any additional intervention and received the same drug and non-drug treatments as the intervention group, based on the opinion of the relevant treatment team according to the latest published version of the national protocol.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Clinical recovery rate. Timepoint: Daily until discharge from the hospital. Method of measurement: No shortness of breath (by patients) + Larger SpO2 equal to 93 (no oxygen uptake) + lower temperature equal to 37.5 ° C for 48 hours.</prim_outcome>
      <prim_outcome>Respiratory rate. Timepoint: The first day before the intervention and daily for 5 days or until discharge, whichever is earlier. Method of measurement: Number of breaths per 1 minute.</prim_outcome>
      <prim_outcome>Peripheral blood oxygen saturation in oxygen therapy. Timepoint: The first day before the intervention and daily for 5 days or discharge, whichever is earlier. Method of measurement: Percentage of oxygen after 2 minutes with finger pulse oximeter in 5 minutes apart from oxygen while sitting on the bed.</prim_outcome>
      <prim_outcome>Percentage of peripheral blood oxygen saturation in the absence of oxygen therapy. Timepoint: The first day before the intervention and daily for 5 days or discharge, whichever is earlier. Method of measurement: Percentage of oxygen after 2 minutes with a finger pulse oximeter while sitting on the bed.</prim_outcome>
      <prim_outcome>Intravenous carbon dioxide content. Timepoint: The first day of hospitalization and the fifth day or time of discharge, whichever is earlier. Method of measurement: According to the VBG report.</prim_outcome>
      <prim_outcome>Intravenous oxygen level. Timepoint: The first day of hospitalization and the fifth day or time of discharge, whichever is earlier. Method of measurement: According to the VBG report.</prim_outcome>
      <prim_outcome>Intravenous bicarbonate. Timepoint: The first day of hospitalization and the fifth day or time of discharge, whichever is earlier. Method of measurement: According to the VBG report.</prim_outcome>
      <prim_outcome>Intravenous blood pH. Timepoint: The first day of hospitalization and the fifth day or time of discharge, whichever is earlier. Method of measurement: According to the VBG report.</prim_outcome>
      <prim_outcome>Severity of dyspnea. Timepoint: The first day before the intervention and daily for 5 days or discharge, whichever is earlier. Method of measurement: Based on Modified Borg Standard Questionnaire 0-10 scale (MBS).</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: The first day before the intervention and daily for 5 days or discharge, whichever is earlier. Method of measurement: With the same standard sphygmomanometer cuff while the patient is sitting on the bed for 10 minutes.</prim_outcome>
      <prim_outcome>Sex. Timepoint: the first day. Method of measurement: Being male or female.</prim_outcome>
      <prim_outcome>Stress level. Timepoint: The first day before the intervention and daily for 5 days or discharge, whichever is earlier. Method of measurement: Based on the standard Zung Self-Rating Anxiety Scale (SAS).</prim_outcome>
      <prim_outcome>Duration of hospitalization. Timepoint: From the first day of hospitalization until discharge. Method of measurement: Number of days elapsed until discharge.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>One-month mortality rate for any reason. Timepoint: One month after enrollment. Method of measurement: telephone follow-up.</sec_outcome>
      <sec_outcome>3-month mortality rate for any reason. Timepoint: 3 months after enrollment. Method of measurement: telephone follow-up.</sec_outcome>
      <sec_outcome>The need for intubation. Timepoint: Until discharge from the hospital. Method of measurement: Number of intubated patients based on the opinion of the relevant treatment team.</sec_outcome>
      <sec_outcome>The need for hospitalization in the intensive care unit. Timepoint: Until discharge from the hospital. Method of measurement: Number of patients admitted to the intensive care unit based on the opinion of the relevant treatment team.</sec_outcome>
      <sec_outcome>Maximum exhaled exhaust air pressure in the first second. Timepoint: 3 months after the time of enrollment. Method of measurement: According to spirometry reports.</sec_outcome>
      <sec_outcome>Maximum amount of exhaust air. Timepoint: 3 months after the time of enrollment. Method of measurement: According to spirometry reports.</sec_outcome>
      <sec_outcome>Ratio of exhaust air loss from the first second to the total. Timepoint: 3 months after the time of enrollment. Method of measurement: According to spirometry reports.</sec_outcome>
      <sec_outcome>Overall carbon monoxide emission capacity. Timepoint: 3 months after the time of enrollment. Method of measurement: According to spirometry reports.</sec_outcome>
      <sec_outcome>Mileage in 3 minutes. Timepoint: 3 months after the time of enrollment. Method of measurement: Based on standard 3-minute walk distance test (6MWD).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-31</approval_date>
        <contact_name>Research Ethics Committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Imam Hussein Hosp, Shahid Madani St, Teharan Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
